Seagen (SGEN) - P/S ratio

P/S ratio on February 9, 2024 (TTM) : 18.8

According to Seagen 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 16.9. At the end of 2023 the company had a P/S ratio of 17.3.

P/S ratio history for Seagen from 2002 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	17.3	42.37%
2022	12.2	-32.29%
2021	18.0	24.61%
2020	14.4	-32.78%
2019	21.4	54.56%
2018	13.9	-13.14%
2017	16.0	-10.62%
2016	17.9	-4.02%
2015	18.6	33.99%
2014	13.9	-23.53%
2013	18.2	38.06%
2012	13.2	-35.13%
2011	20.3	43.5%
2010	14.1	-28.11%
2009	19.7	-9.49%
2008	21.7	-36.73%
2007	34.3	26.3%
2006	27.2	32.6%
2005	20.5	-49.89%
2004	40.9	-24.52%
2003	54.2	-4.09%
2002	56.5

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
ImmunoGen IMGN	30.3	61.69%	🇺🇸 USA
Biogen BIIB	2.26	-87.95%	🇺🇸 USA
Celldex Therapeutics CLDX	167	790.85%	🇺🇸 USA
Spectrum Pharmaceuticals SPPI	8.22	-56.20%	🇺🇸 USA
Pfizer PFE	2.52	-86.56%	🇺🇸 USA
GlaxoSmithKline GSK	1.72	-90.81%	🇬🇧 UK
AbbVie ABBV	5.73	-69.47%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.47	-86.84%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Seagen (SGEN)

P/S ratio on February 9, 2024 (TTM) : 18.8